Orthofix Medical Inc. (OFIX) Q3 2026 earnings results
Orthofix Medical Inc. (OFIX) reported Q3 2026 results on Nov 9, 2026, 8:01:00 AM ET: GAAP EPS -$0.15 vs. $0.11 expected (miss by $0.26); revenue $207.86M vs. $210.52M expected (miss by 1.3%). Outlook: Full-year 2026 net sales guidance revised to $825 million to $830 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | -$0.15 | $0.11 | Miss by $0.26 |
| Revenue | $207.86M | $210.52M | Miss by 1.3% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 9, 2026, 8:01:00 AM ET. Nexqual published them 63 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 1.1% from $205.63M; GAAP diluted EPS was -$0.15 vs. -$0.57 (+73.7%).
Stock reaction
The results came out before the market opened. OFIX closed at $7.90 on November 9, 2026, up 0.4% from its $7.87 close on November 6, 2026 before the results. Latest: $7.20 as of 11:45 AM ET, −8.5% since the pre-release close.
Questions and answers
Did Orthofix Medical Inc. beat earnings expectations?
No. Orthofix Medical Inc. reported GAAP EPS of -$0.15 against an average analyst estimate of $0.11 (miss by $0.26), and revenue of $207.86M against $210.52M expected (miss by 1.3%).
What were Orthofix Medical Inc.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of -$0.15 and revenue of $207.86M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 1.1% from $205.63M; GAAP diluted EPS was -$0.15 vs. -$0.57 (+73.7%).
When did Orthofix Medical Inc. report Q3 2026 earnings?
Nov 9, 2026, 8:01:00 AM ET, in an SEC 8-K filing (Item 2.02).
How did OFIX stock react to the earnings?
The results came out before the market opened. OFIX closed at $7.90 on November 9, 2026, up 0.4% from its $7.87 close on November 6, 2026 before the results. Latest: $7.20 as of 11:45 AM ET, −8.5% since the pre-release close.
What did Orthofix Medical Inc. say about its outlook?
Full-year 2026 net sales guidance revised to $825 million to $830 million.
More on OFIX
OFIX stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 9, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:45 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:45 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt